Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
P2 VAC
- Development stage
- Unknown
- Lead developer
- Vetal Animal Health Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
**P2 VAC** is a commercial combined veterinary vaccine from Vetal for active immunization of sheep and goats against sheep and goat pox and peste des petits ruminants. It is a freeze-dried live-attenuated viral vaccine that is reconstituted before administration; the manufacturer specifies a 1 mL dose and annual revaccination following the initial vaccination schedule. ([vetal.com.tr](https://www.vetal.com.tr/en/urun/p2-vac-combined-pox-and-ppr-vaccine))
- Brand names
- P2 VACP-2 VACP 2 VAC
- Other names
- Combined Pox and PPR Vaccine
Beyond the preview
Go deeper on P2 VAC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on P2 VAC.